Central Trust Company’s Innoviva INVA Stock Holding History

Central Trust Company’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-400	Closed	-$6K	–	1197
2018 Q3	$6K	Hold	400	–	–	﹤0.01%	1099
2018 Q2	$6K	Buy	+400	New	+$5.99K	﹤0.01%	1089

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Central Trust Company's INVA Position: Q4 2018 in Review

Central Trust Company sold out of Innoviva (INVA) in Q4 2018, closing a stake of 400 shares — an estimated $6K sold.

Central Trust Company first reported a position in INVA in Q2 2018 and held it in 2 quarters. The position peaked at $6K in Q3 2018. 233 funds tracked by Wall St. Rank hold INVA as of Q4 2018.

Central Trust Company reported no remaining Innoviva position as of Q4 2018 after selling out during the quarter.
Central Trust Company sold 400 Innoviva shares in Q4 2018, an estimated $6K.
Central Trust Company first reported a position in Innoviva in Q2 2018 and held it in 2 quarters.
Central Trust Company's Innoviva position peaked at $6K in Q3 2018.
233 funds tracked by Wall St. Rank held Innoviva as of Q4 2018.

Based on Central Trust Company's 13F filing for Q4 2018, filed 8 Jan 2019.